Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

Author:

Hong Shengjun, ,Prokopenko Dmitry,Dobricic Valerija,Kilpert Fabian,Bos Isabelle,Vos Stephanie J. B.,Tijms Betty M.ORCID,Andreasson Ulf,Blennow KajORCID,Vandenberghe Rik,Cleynen Isabelle,Gabel Silvy,Schaeverbeke Jolien,Scheltens PhilipORCID,Teunissen Charlotte E.,Niemantsverdriet Ellis,Engelborghs SebastiaanORCID,Frisoni Giovanni,Blin Olivier,Richardson Jill C.,Bordet Regis,Molinuevo José Luis,Rami Lorena,Kettunen PetronellaORCID,Wallin AndersORCID,Lleó Alberto,Sala Isabel,Popp Julius,Peyratout Gwendoline,Martinez-Lage Pablo,Tainta Mikel,Dobson Richard J. B.ORCID,Legido-Quigley Cristina,Sleegers KristelORCID,Van Broeckhoven Christine,ten Kate Mara,Barkhof Frederik,Zetterberg HenrikORCID,Lovestone Simon,Streffer Johannes,Wittig Michael,Franke AndreORCID,Tanzi Rudolph E.ORCID,Visser Pieter JelleORCID,Bertram LarsORCID

Abstract

AbstractAlzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case–control designs. Elucidating the genetic architecture of additional AD-related phenotypic traits, ideally those linked to the underlying disease process, holds great promise in gaining deeper insights into the genetic basis of AD and in developing better clinical prediction models. To this end, we generated genome-wide single-nucleotide polymorphism (SNP) genotyping data in 931 participants of the European Medical Information Framework Alzheimer’s Disease Multimodal Biomarker Discovery (EMIF-AD MBD) sample to search for novel genetic determinants of AD biomarker variability. Specifically, we performed genome-wide association study (GWAS) analyses on 16 traits, including 14 measures derived from quantifications of five separate amyloid-beta (Aβ) and tau-protein species in the cerebrospinal fluid (CSF). In addition to confirming the well-established effects of apolipoprotein E (APOE) on diagnostic outcome and phenotypes related to Aβ42, we detected novel potential signals in the zinc finger homeobox 3 (ZFHX3) for CSF-Aβ38 and CSF-Aβ40 levels, and confirmed the previously described sex-specific association between SNPs in geminin coiled-coil domain containing (GMNC) and CSF-tau. Utilizing the results from independent case–control AD GWAS to construct polygenic risk scores (PRS) revealed that AD risk variants only explain a small fraction of CSF biomarker variability. In conclusion, our study represents a detailed first account of GWAS analyses on CSF-Aβ and -tau-related traits in the EMIF-AD MBD dataset. In subsequent work, we will utilize the genomics data generated here in GWAS of other AD-relevant clinical outcomes ascertained in this unique dataset.

Publisher

Springer Science and Business Media LLC

Subject

Biological Psychiatry,Cellular and Molecular Neuroscience,Psychiatry and Mental health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3